53 results on '"Kastelein J"'
Search Results
2. Supplement to: Simvastatin with or without ezetimibe in familial hypercholesterolemia.
3. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia
4. Effect of periodontal treatment on risk factors of cardiovascular diseases. A systematic review and metaanalyses.: TR 38
5. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin
6. Reducing cardiovascular disease risk in patients with type 2 diabetes and concomitant macrovascular disease: can insulin be too much of a good thing?
7. Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy†
8. Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial
9. Pink-creamy whole blood in a 3-month-old infant with a homozygous deletion in the lipoprotein lipase gene
10. Physical inactivity, abdominal obesity and risk of coronary heart disease in apparently healthy men and women
11. Heterozygous familial hypercholesterolaemia in childhood: Cardiovascular risk prevention
12. Dalcetrapib: no off-target toxicity on blood pressure or on genes related to the renin-angiotensin-aldosterone system in rats
13. Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study
14. Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis
15. ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans
16. Combination statin–fibrate therapy: safety aspects
17. Triglycerides and Cardiovascular Risk
18. Arterial stiffness, endothelial function and microcirculatory reactivity in healthy young males
19. Systemic inflammation as a risk factor for atherothrombosis
20. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study
21. Normalization of metabolic syndrome using fenofibrate, metformin or their combination
22. Cardiovascular metabolic syndrome – an interplay of, obesity, inflammation, diabetes and coronary heart disease
23. Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemia
24. Results from a rosuvastatin historical cohort study in more than 45 000 Dutch statin users, a PHARMO study†
25. Increased inflammatory markers in children with familial hypercholesterolaemia
26. Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels
27. Ezetimibe/simvastatin (INEGY™) in the treatment of hyperlipidaemia
28. Achieving lipid goals in real life: the Dutch DISCOVERY Study
29. Carotid intima–media thickness in post-coarctectomy patients with exercise induced hypertension
30. High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent
31. Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?
32. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients
33. The Spectrum of Statin Therapy in Hyperlipidemic Children
34. HDL deficiency and atherosclerosis: lessons from Tangier disease
35. Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia
36. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)
37. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia
38. Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia
39. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia
40. Parental attitude towards genetic testing for familial hypercholesterolaemia in children
41. Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia
42. The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease
43. Results from a family and DNA based active identification programme for familial hypercholesterolaemia
44. Increased risk for ischaemic events is related to combined RAS polymorphism
45. Screening for familial hypercholesterolaemia : Effective, safe treatments and DNA testing make screening attractive
46. Low-density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia
47. The effect of cholesterol lowering on carotid and femoral artery wall stiffness and thickness in patients with familial hypercholesterolaemia
48. The 20210 G [arrow right] A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease
49. Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease
50. Working group on epidemiology & prevention of the european society of cardiology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.